Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1Phase 1/2 1

Status

Active not recruiting 48Recruiting 39Completed 11Suspended 5Not yet recruiting 5Terminated 3Withdrawn 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Head & Neck 1

Conditions

Pancreatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Carcinoma 1Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 60Magnetic Resonance Spectroscopy 43Carboplatin 33Cyclophosphamide 31Gemcitabine 28Biopsy 26Cisplatin 25pembrolizumab 24Bevacizumab 24Paclitaxel 23Injections 22Standard of Care 21Radiotherapy 21Drug Therapy 21Capecitabine 21fludarabine 20venetoclax 19Oxaliplatin 19toripalimab 17Nivolumab 17Interviews as Topic 17Dexamethasone 17Blood Specimen Collection 16anlotinib 15Radiosurgery 15tislelizumab 14Azacitidine 14cemiplimab 13Pemetrexed 13Irinotecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × Taxes × 90 days × Clear all
NCT07618910 2026-06-01

Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC

Tang-Du Hospital

Phase 2 Not yet recruiting
33 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT07594548 2026-05-18

Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Northwestern University

Phase 1 Not yet recruiting
18 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus

NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology

Phase 3 Not yet recruiting
454 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT07488884 2026-04-29

ResQ108B-PANC

ImmunityBio, Inc.

Phase 1 Not yet recruiting
30 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT07444541 2026-04-16

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Anova Innovation Limited

Phase 1/2 Not yet recruiting
84 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡